KRAS and neoplasm: In human tumour xenograft models, BAY 43-9006 significantly delayed tumour growth of colon, pancreatic, and non-small-cell lung cancer (NSCLC) models containing either B-Raf or K-Ras mutations (Wilhelm et al, 2004).